Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Revolution Ascend

GE Revolution Ascend

Enovacom EPC

Enovacom EPC

Research & Development

$5.7M investment for better treatment of sepsis

July 29, 2020


Dr Alison Fox-RobichaudHAMILTON, Ont. – An investment of $5.7 million from the Government of Canada, through the Canadian Institutes of Health Research (CIHR), will support a new national research network – Sepsis Canada – to improve the treatment and recovery of sepsis patients.

Sepsis is a life-threatening condition that results from an out-of-control immune response to an infection that may lead to tissue damage, organ failure and death. Children, seniors, those with chronic health conditions like diabetes, cancer or immunodeficiency, and members of certain groups such as Indigenous Peoples, new immigrants to Canada, and those with unstable housing are especially vulnerable.

The source of infection in sepsis can be a microbial pathogen such as a virus or bacterium. The new coronavirus that causes COVID-19 is now on the list of pathogens that cause sepsis. Most patients critically ill with COVID-19 develop sepsis, which becomes a major threat to their survival.

Led by Dr. Alison Fox-Robichaud (pictured), Sepsis Canada will track and study treatments for septic patients, and develop a bank of evidence-based tools to educate the public and healthcare professionals about how to best prevent, diagnose and manage sepsis. The network will also collect data that will give a true understanding of the burden of sepsis in Canada. A recent global report published in the journal Lancet estimated that 75,000 cases of sepsis occur in Canada every year, likely causing 18,000 deaths.

“Canadians should be aware that sepsis, a life-threatening response to an infection, is a global health issue and never is this more apparent than during the current pandemic,” said Dr. Fox-Robichaud, scientific director, Sepsis Canada and a professor at McMaster University.

“Our team of scientists, knowledge users, patient and family members and partners are prepared to change the story within our country. We will do this by better understanding the epidemiological and financial burden of sepsis in Canada, and by understanding and improving the long-term outcomes of sepsis survivors.”

The team intends to improve the understanding the complex interactions between predisposing conditions, the infections that cause sepsis and the immune-system response, and to discover new evidence-based cost-effective therapies.

“Sepsis is a serious and complex medical condition that is best addressed using a muti -disciplinary team approach,” said Dr. Brian Rowe, scientific director, CIHR Institute of Circulatory and Respiratory Health. “By bringing together healthcare workers, researchers, patients and advocates, the CIHR support for Sepsis Canada will help ensure that we find the most effective and enduring approaches to mitigate this critical and long-standing health challenge.”

PreviousNext

SteraMist (Feb)

SteraMist (Feb)

News and Trends

  • RACE streamlines patient journey
  • Healthcare supply chain needs a re-think, observers say
  • EDI spots pricing anomalies in Ontario’s healthcare supply chain
  • AI centres of excellence and companies collaborate on apps
  • Talking Stick: New hope for Indigenous mental healthcare
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

Nihi Data [Winter 2023]

Nihi Data [Winter 2023]

WP

WP

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

Zebra

Zebra

CHT print-200×400

CHT print-200x400

SteraMist (Feb)

SteraMist (Feb)

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

Zebra

Zebra

CHT print-200×400

CHT print-200x400

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2023 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us